GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,000 shares of the company's stock, valued at approximately $325,000.
A number of other institutional investors also recently made changes to their positions in the company. MML Investors Services LLC increased its position in Clorox by 9.7% during the third quarter. MML Investors Services LLC now owns 8,959 shares of the company's stock worth $1,460,000 after acquiring an additional 792 shares during the period. Virtu Financial LLC bought a new position in shares of Clorox during the third quarter worth approximately $714,000. Diamant Asset Management Inc. raised its position in shares of Clorox by 12.5% in the third quarter. Diamant Asset Management Inc. now owns 2,250 shares of the company's stock valued at $367,000 after buying an additional 250 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in shares of Clorox by 9.2% in the third quarter. Sanctuary Advisors LLC now owns 22,102 shares of the company's stock valued at $3,742,000 after buying an additional 1,864 shares during the period. Finally, Wilmington Savings Fund Society FSB grew its position in Clorox by 12.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 10,366 shares of the company's stock worth $1,689,000 after buying an additional 1,150 shares in the last quarter. Institutional investors own 78.53% of the company's stock.
Clorox Trading Down 0.5 %
Shares of CLX stock traded down $0.69 during trading hours on Monday, hitting $139.09. 131,018 shares of the company's stock traded hands, compared to its average volume of 1,299,733. The stock has a market cap of $17.13 billion, a PE ratio of 38.00, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61. The stock's 50 day simple moving average is $146.57 and its 200 day simple moving average is $156.36. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company posted $2.16 earnings per share. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.51%. Clorox's payout ratio is 133.33%.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. Citigroup dropped their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Barclays decreased their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. UBS Group decreased their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research report on Thursday. Finally, DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $153.83.
Check Out Our Latest Analysis on CLX
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
